Henry Schein Inc
NASDAQ:HSIC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
63.92
80.57
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Henry Schein Inc
Henry Schein Inc
Revenue
Henry Schein Inc
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Revenue
$12.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Cardinal Health Inc
NYSE:CAH
|
Revenue
$224.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Adapthealth Corp
NASDAQ:AHCO
|
Revenue
$4.1B
|
CAGR 3-Years
25%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Revenue
$6.5B
|
CAGR 3-Years
1%
|
CAGR 5-Years
3%
|
CAGR 10-Years
6%
|
|
|
Mckesson Corp
NYSE:MCK
|
Revenue
$330.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
8%
|
CAGR 10-Years
8%
|
|
|
Cencora Inc
NYSE:COR
|
Revenue
$294B
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
Henry Schein Inc
Revenue Breakdown
Breakdown by Geography
Henry Schein Inc
|
Total Revenue:
12.3B
USD
|
|
North America:
9.1B
USD
|
|
United States:
8.6B
USD
|
|
Locations Other Than United States:
3.7B
USD
|
|
International:
3.2B
USD
|
Breakdown by Segments
Henry Schein Inc
|
Total Revenue:
12.3B
USD
|
|
Healthcare Distribution:
11.5B
USD
|
|
Technology:
806m
USD
|
Henry Schein Inc
Glance View
Henry Schein Inc. is a global leader in healthcare distribution, primarily serving dental, medical, and veterinary markets. Founded in 1932, the company has built a robust reputation by providing a comprehensive range of products and services, including medical and dental supplies, laboratory equipment, and software solutions that streamline practice management. With its headquarters in Melville, New York, Henry Schein operates in over 30 countries, leveraging its extensive distribution network and strategic partnerships to deliver top-quality products and innovative healthcare solutions. Investors will appreciate the company's consistent revenue growth and resilience, even during economic fluctuations, highlighting its essential role in the healthcare ecosystem. As the healthcare landscape evolves, Henry Schein is positioned to thrive. The increasing demand for healthcare services, particularly in dental and geriatric care, fuels the company’s expansion prospects. Its commitment to innovation is reflected in its investments in technology and digital solutions, allowing healthcare providers to enhance patient care and operational efficiency. Furthermore, Henry Schein’s focus on sustainability and social responsibility resonates with growing investor interest in ethical business practices. For those considering investment, the company not only boasts a solid financial track record but also demonstrates a commitment to adapting to the changing healthcare environment, making it an attractive option for long-term growth in the healthcare sector.
See Also
What is Henry Schein Inc's Revenue?
Revenue
12.5B
USD
Based on the financial report for Sep 28, 2024, Henry Schein Inc's Revenue amounts to 12.5B USD.
What is Henry Schein Inc's Revenue growth rate?
Revenue CAGR 10Y
2%
Over the last year, the Revenue growth was -2%. The average annual Revenue growth rates for Henry Schein Inc have been 1% over the past three years , 5% over the past five years , and 2% over the past ten years .
You don't have any saved screeners yet
